Progesterone Receptors A and B Differentially Affect the Growth of Estrogen-Dependent Human Breast Tumor Xenografts Carol A. SartoriusTianjie ShenKathryn B. Horwitz OriginalPaper Pages: 287 - 299
Inositol Hexaphosphate (IP6) Enhances the Anti-Proliferative Effects of Adriamycin and Tamoxifen in Breast Cancer Kwanchanit TantivejkulIvana VucenikAbulKalam M. Shamsuddin OriginalPaper Pages: 301 - 312
Growth and Fatty Acid Metabolism of Human Breast Cancer (MCF-7) Xenografts in Nude Rats: Impact of Constant Light-Induced Nocturnal Melatonin Suppression David E. BlaskRobert T. DauchyGeorge C. Brainard OriginalPaper Pages: 313 - 320
JNK/SAPK Mediates Doxorubicin-Induced Differentiation and Apoptosis in MCF-7 Breast Cancer Cells Jayoung KimMichael R. Freeman OriginalPaper Pages: 321 - 328
Ornithine Decarboxylase (ODC) as a Prognostic Factor in Operable Breast Cancer Richard R. LoveStephanie H. AstrowThomas C. Havighurst OriginalPaper Pages: 329 - 334
Effect of Ligands of Nuclear Hormone Receptors on Sodium/Iodide Symporter Expression and Activity in Breast Cancer Cells Sakae TanosakiTakayuki IkezoeH. Phillip Koeffler OriginalPaper Pages: 335 - 345
Incidence of Anaemia in Breast Cancer Patients Receiving Adjuvant Chemotherapy Ursula DenisonJose BaumannPaul Sevelda OriginalPaper Pages: 347 - 353
HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites Robert MillikanAllison EatonLynn Dressler OriginalPaper Pages: 355 - 364
Long Term Inhibition by Estradiol or Progesterone of Melatonin Secretion After Administration of a Mammary Carcinogen, the Dimethyl Benz(a)anthracene, in Sprague-Dawley Female Rat; Inhibitory Effect of Melatonin on Mammary Carcinogenesis Marianne Beau Yon De Jonage-CanonicoVéronique LenoirBernard Kerdelhué OriginalPaper Pages: 365 - 377
Progesterone Receptor Expression in Medroxyprogesterone Acetate-Induced Murine Mammary Carcinomas and Response to Endocrine Treatment Luisa A. HelgueroMarcelo ViegasAlfredo A. Molinolo OriginalPaper Pages: 379 - 390
Use of the Peroxisome Proliferator-Activated Receptor (PPAR) γ Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study Harold J. BursteinGeorge D. DemetriEric P. Winer OriginalPaper Pages: 391 - 397
Role of CRE-Binding Protein (CREB) in Aromatase Expression in Breast Adipose Mariam SofiMorag J. YoungColin D. Clyne OriginalPaper Pages: 399 - 407
Polymorphisms in the Estrogen Receptor Beta Gene and Risk of Breast Cancer: No Association Asta FörstiChunyan ZhaoKari Hemminki OriginalPaper Pages: 409 - 413